In this Friday’s PCT Grand Rounds, Mikhail Kosiborod of the University of Missouri-Kansas City will present “Collaborative Pragmatic Trials in Action: EVOLVE-MI.”
The Grand Rounds session will be held on Friday, January 20, 2023, at 1:00 pm eastern.
Kosiborod is a cardiologist, the vice president of research at Saint Luke’s Health System, and a professor of medicine at the University of Missouri-Kansas City. EVOLVE-MI is a pragmatic clinical trial evaluating the impact of rapid and intensive cholesterol lowering in patients who receive evolocumab within 10 days of a non-ST-elevation myocardial infarction or ST-elevation myocardial infarction.